Inhibition of Cytochromes P450: Existing and New Promising Therapeutic Targets
Authors:
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 39 (2-3) , 481-499
Abstract
Mammalian cytochromes P450 have been shown to play highly important roles in the metabolism of drugs and xenobiotics as well as in the biosynthesis of a variety of endogenous compounds, many of them displaying hormonal function. The role of P450s as therapeutic targets is still inadequately recognized although several P450 inhibitors became efficient drugs that even reached blockbuster status. Here, we try to give a comprehensive overview on cytochromes P450s, which are already well-established targets – particularly focussing on the treatment of infectious diseases, metabolic disorders and cancer – and on those, which have a high potential to become successful targets. In addition, the design of inhibitors of cytochromes P450 will be discussed.Keywords
This publication has 84 references indexed in Scilit:
- Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdomsBiochimica et Biophysica Acta (BBA) - General Subjects, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Improving the outcome of patients with castration-resistant prostate cancer through rational drug developmentBritish Journal of Cancer, 2006
- Structural basis for ligand promiscuity in cytochrome P450 3A4Proceedings of the National Academy of Sciences, 2006
- Function of human cytochrome P450s: Characterization of the orphansBiochemical and Biophysical Research Communications, 2005
- Noncalcemic Actions of Vitamin D Receptor LigandsEndocrine Reviews, 2005
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesisJournal of Medicinal Chemistry, 1990
- 17β-(Cyclopropylamino)-androst-5-en-3β-ol, a selective mechanism-based inhibitor of cytochrome P45017α (steroid 17α-hydroxylase/C17–20 lyase)Biochemical and Biophysical Research Communications, 1989
- Inhibitory effect and interaction of stanozolol with pig testicular cytochrome P-450 (17.ALPHA.-hydroxylase/C17.20-lyase).Chemical and Pharmaceutical Bulletin, 1989